GDRX
GoodRx Holdings, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$3.38
−0.59%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- $0.08
- Revenue estimate
- $201.9M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.08
- EPS estimate
- $0.08
- Revenue actual
- $200.4M
- Revenue estimate
- $193.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 5
- Avg surprise (4Q)
- -3.1%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $4.55
- PT range
- $3.75 – $5.00
- Analysts
- 6
4 Buy1 Hold1 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.08 | $0.08 | In line | $200.4M |
| May 7, 2026 | $0.07 | $0.07 | Miss -1.41% | $194.0M |
| Feb 26, 2026 | $0.09 | $0.09 | In line | $194.8M |
| Nov 4, 2025 | $0.09 | $0.08 | Miss -11.11% | $196.0M |
| Aug 6, 2025 | $0.10 | $0.09 | Miss -10.00% | $203.1M |
| May 7, 2025 | $0.09 | $0.09 | In line | $203.0M |
| Feb 27, 2025 | $0.10 | $0.09 | Miss -10.00% | $198.6M |
| Nov 7, 2024 | $0.09 | $0.08 | Miss -11.11% | $195.3M |
| Aug 8, 2024 | $0.09 | $0.08 | Miss -11.11% | $200.6M |
| May 9, 2024 | $0.09 | $0.08 | Miss -11.11% | $197.9M |
| Feb 29, 2024 | $0.08 | $0.08 | In line | $196.6M |
| Nov 9, 2023 | $0.06 | $0.06 | In line | $180.0M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026